BiomX Insider Moves: Reuven’s Conversion‑Sell Boosts Liquidity Before Dilution
BiomX insider activity shows Yeganeh Reuven converting preferred stock to common and selling at $5.00, revealing short‑term liquidity moves amid potential dilution.
3 minutes to read